Research Involving Recombinant or Synthetic Nucleic Acid Molecules

Research with recombinant or synthetic nucleic acid molecules within the U.S. or its territories conducted at or sponsored by an institution that receives any support for research with recombinant or synthetic nucleic acid molecules from the National Institutes of Health (NIH) must comply with the most recent guidelines as published in the Federal Register. The guidelines specify practices for constructing and handling recombinant or synthetic nucleic acid molecules and organisms and viruses containing recombinant or synthetic nucleic acid molecules.

The Institutional Biosafety Committee has been established at Kansas State University in accordance with the NIH Guidelines to oversee research with recombinant or synthetic nucleic acid. All research with recombinant or synthetic nucleic acid molecules must be registered with the IBC, even if those studies are exempt from the above guidelines. Information can be obtained from the University Research Compliance Office concerning the committee.